The progesterone‐related increase in mean FSH appeared to exceed the placebo‐related increase in PCOS (ratio of GM ratios 1.30 [95% CI 1.04–1.63]; p = 0.024), although this difference was not significant after Bonferroni correction (p = 0.072). Here, BRD2 is linked to polycystic ovary syndrome.